Zika Virus Testing Market Will Be Worth $580.4 Million By 2027: Grand View Research, Inc.
The
global zika virus testing market size is expected to
reach USD 580.4 million by 2027, according to a new report by Grand View
Research, Inc., progressing at a CAGR of 7.6% during the forecast period. Zika
virus outbreak in 2016 contributed to the rise in response strategies and
diagnostic surveillance activities. Widespread incidence of the disease in 2016
was mostly a result of travel-based viral transmission. The recently drawn
correlation between Zika virus infection and microcephaly in newborns is
further stoking growth of the market.
Spiraling
demand for Zika Virus Testing stems from government-led preparedness programs
and support from international organizations such as UNICEF. Stockpiling and
emergency preparedness initiatives focus on endemic regions as well as
immunologically naïve population subsets in the Asian and African markets,
which hold high threat of future outbreaks. These developing regions, currently
not classified as endemic, are host to temperature changes, humidity, and
precipitation as well as reported vector presence that cumulatively provide a
supportive habitat for the causative vector, Aedes aegypti mosquitoes.
Browse full
research report on Zika Virus Testing Market: www.grandviewresearch.com/industry-analysis/zika-virus-testing-market
Further key
findings from the study suggest:
- NAAT and serological segments in the Zika Virus
Testing market held nearly equal market share in 2016. However, the former
was preferred for its cost effectiveness in analyzing high volume of tests
during the epidemic
- Serological tests are gaining preference as
they can provide differential diagnosis and are performed to detect
late-stage infections
- In 2016, the U.S. states and territories
dominated the market in terms of revenue. Increasing blood donation
screening using individual donor NAAT tests to prevent transfusion-related
disease transmission is one of key factors contributing to the market.
- Latin America followed in terms of market share
as it witnessed more than 50% of the globally recorded disease incidence
in 2016. Brazil’s National Development Bank announced funding worth USD
136.6 million, which will drive disease surveillance activities with
improved rapid tests to fight zika virus infection in the country
- UNICEF awarded long-term arrangement contracts,
effective until 2019, to Chembio Diagnostic Systems, Inc. and SD
Biosensors, Inc. for the supply of ZIKV diagnostics
- In 2016, Quest Diagnostics, Inc.; Roche; and
Hologic were among the leading market players with FDA-approved
diagnostics under emergency use authorization
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the global Zika Virus Testing market
based on test type and region:
Zika Virus
Testing Test Type Outlook (Revenue, USD Million, 2016-2027)
- Nucleic
Acid Amplification Testing (NAAT)
- Serological
Testing
Zika Virus
Testing Regional Outlook (Revenue, USD Million, 2016-2027)
- U.S.
States & Territories
- U.S.
States
- U.S.
Territories
- Europe
- Continental
Europe
- Caribbean
- Asia
Pacific
- Singapore
- Vietnam
- Indonesia
- Latin
America
- Brazil
- Colombia
- Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-zika-virus-testing-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment